CorMedix Inc (CRMD) support and resistance · P/E 3.9, rev $43.5M
CorMedix Inc (CRMD) is a biotechnology company listed on US.
This page maps CorMedix Inc (CRMD) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CRMD revenue for 2024-12-31 was $43.5M. Net income was -$17.9M. Revenue was up 66363.1% from 2022-12-31 to 2024-12-31. CRMD currently screens at market cap $655.9M and trailing P/E 3.9.
CRMD currently screens at market cap $655.9M and trailing P/E 3.9. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CRMD 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CRMD quote page for the session range and the stock page for the full model.
Not investment advice.